AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma

Condition:   Angiosarcoma Interventions:   Drug: AGEN2034;   Drug: AGEN1884 Sponsor:   Agenus Inc. Not yet recruiting

Source: ClinicalTrials.gov - October 29, 2020 Category: Research Source Type: clinical trials